TNN - jaargang 122, nummer 2, maart 2021
dr. J. Derdelinckx
Op 22 juni 2020 promoveerde Judith Derdelinckx aan de Universiteit Antwerpen op het proefschrift getiteld ‘Towards a “negative” cellular vaccine for the treatment of multiple sclerosis: counteracting epitope spreading for long-lasting tolerance induction using mRNA-electroporated tolerogenic dendritic cells’. Het onderzoek werd verricht onder leiding van promotoren prof. dr. Z. Berneman, prof. dr. N. Cools en prof. dr. P. Cras. In dit artikel worden de belangrijkste bevindingen besproken.
(TIJDSCHR NEUROL NEUROCHIR 2021;122(2):78-80)
Lees verderTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.